IsoPlexis (www.isoplexis.com) is dedicated to accelerating the fight against cancer and a range of the world's toughest diseases with its uniquely correlative, award-winning, single-cell detection systems. By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise and personalized stage. Our integrated systems, named #1 innovation by the Scientist Magazine and Fierce, are used globally to advance the field of single-cell biology and biomarkers as we generate solutions to overcome the challenges of complex diseases.
BiotechEquipment & Device Manufacturers
Products & Services
Documents & Links
Discover Our Unique BiologyDiscover how IsoPlexis' innovation has allowed us to be the only company able to detect the range of functional extracellular proteins per single cell.
IsoPlexis Application NotesExplore the data sets and resources most relevant to your research areas.